sulforaphane has been researched along with Cardiovascular Diseases in 10 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "SFN may prevent different types of cancer and has the ability to improve hypertensive states, to prevent type 2 diabetes-induced cardiomyopathy, and to protect against gastric ulcer." | 2.72 | Potential of Sulforaphane as a Natural Immune System Enhancer: A Review. ( Castillo, A; Mahn, A, 2021) |
| " However, species, disease model, duration, SFN dosage as well as route of administration did not explain the heterogeneity among studies." | 2.72 | Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis. ( Du, K; Fan, Y; Li, D, 2021) |
| " To allow comparison between rodent and human studies, we discuss the published bioavailability of SFN metabolites achieved in rodents and man in the context of Nrf2, NFκB and PPARγ signaling." | 2.58 | Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome. ( Chapple, SJ; Mann, GE; Patel, B, 2018) |
| "Sulforaphane (SFN) is an ITC shown to possess anticancer activities by both in vivo and epidemiological studies." | 2.52 | Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation. ( Bai, Y; Cui, J; Ma, C; Wang, X; Zhao, S; Zheng, Y, 2015) |
| "Sulforaphane is an isothiocyanate derived from cruciferous vegetables, and it has gained attention mainly as a potential chemopreventive agent in part through the induction of detoxifying enzymes." | 1.35 | Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential. ( Angelini, S; Angeloni, C; Hrelia, P; Hrelia, S; Leoncini, E; Malaguti, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olcum, M | 1 |
| Tastan, B | 1 |
| Ercan, I | 1 |
| Eltutan, IB | 1 |
| Genc, S | 1 |
| Mahn, A | 1 |
| Castillo, A | 1 |
| Du, K | 1 |
| Fan, Y | 1 |
| Li, D | 1 |
| Patel, B | 1 |
| Mann, GE | 1 |
| Chapple, SJ | 1 |
| Palliyaguru, DL | 1 |
| Yuan, JM | 1 |
| Kensler, TW | 1 |
| Fahey, JW | 1 |
| Pulakazhi Venu, VK | 1 |
| El-Daly, M | 1 |
| Saifeddine, M | 1 |
| Hirota, SA | 1 |
| Ding, H | 1 |
| Triggle, CR | 1 |
| Hollenberg, MD | 1 |
| Malaguti, M | 2 |
| Angeloni, C | 2 |
| Hrelia, S | 2 |
| Bai, Y | 1 |
| Wang, X | 1 |
| Zhao, S | 1 |
| Ma, C | 1 |
| Cui, J | 1 |
| Zheng, Y | 1 |
| Leoncini, E | 1 |
| Angelini, S | 1 |
| Hrelia, P | 1 |
| Vazquez-Prieto, MA | 1 |
| Miatello, RM | 1 |
7 reviews available for sulforaphane and Cardiovascular Diseases
| Article | Year |
|---|---|
Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review.
Topics: Animals; Cardiovascular Diseases; Central Nervous System Diseases; Curcumin; Humans; Inflammasomes; | 2020 |
Potential of Sulforaphane as a Natural Immune System Enhancer: A Review.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Immune System; Isothiocyanates; | 2021 |
Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Isothiocyanates; Lipids; Mice; Non-alcoholic Fa | 2021 |
Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Isothiocyanates; Metabolic | 2018 |
Isothiocyanates: Translating the Power of Plants to People.
Topics: Brassica; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Isot | 2018 |
Nutraceutical Bioactive Compounds Promote Healthspan Counteracting Cardiovascular Diseases.
Topics: Aged; Aged, 80 and over; Aging; Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Diet | 2015 |
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Humans; Isothiocyanates; NF-E2-Re | 2015 |
3 other studies available for sulforaphane and Cardiovascular Diseases
| Article | Year |
|---|---|
Minimizing Hyperglycemia-Induced Vascular Endothelial Dysfunction by Inhibiting Endothelial Sodium-Glucose Cotransporter 2 and Attenuating Oxidative Stress: Implications for Treating Individuals With Type 2 Diabetes.
Topics: Biomarkers; Biopterins; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic | 2019 |
Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Cell Survival; Cells, Cultured; Enzyme Activat | 2009 |
Organosulfur compounds and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Diet; Fruit; Humans; Isothiocyanates; Models, Animal; Sulfoxides; | 2010 |